News

PharmExec9h
AstraZeneca, CSPC Launch AI-Powered Collaboration for Oral Drug Discovery
Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...
Business Weekly10h
AstraZeneca takes spending on novel China projects to around $8bn
Cambridge headquartered global pharmaceutical company AstraZeneca took its spending on China plays in the last month to ...
AstraZeneca slips Monday, underperforms market
AstraZeneca PLC closed 19.20% below its 52-week high of £133.88, which the company achieved on September 3rd.
AstraZeneca Unit Owes $180 Million-Plus in Syntimmune Case (1)
An AstraZeneca Plc affiliate suffered a greater than $180 million court loss Wednesday over its lackluster efforts to ...
KSL10d
AstraZeneca sues Utah attorney general over new Utah drug price law
The pharmaceutical drug company AstraZeneca filed a lawsuit against the Utah attorney general claiming Utah's new law on ...
AstraZeneca sues Utah attorney general over new drug pricing law
AstraZeneca, a major pharmaceutical company, has sued Utah’s Attorney General Derek Brown over a recently passed state law ...
Explore more
Fierce Pharma11h
AstraZeneca touts early Ultomiris survival data in children living with rare post-transplant complication
Now that Ultomiris has matched the indications of its predecessor Soliris, AstraZeneca is eyeing new avenues for the C5 drug ...
EHA 2025: AstraZeneca’s surovatamig is potential next-gen BiTE for R/R B-ALL
This trial evaluated the safety, tolerability, pharmacodynamics, pharmacokinetics and clinical activity of AstraZeneca’s ...